ストックスクリーナーアプリを入手
342.35
1.13%
-3.93
アフターアワーズ：
342.00
-0.35
-0.10%
前日終値:
$346.28
開ける：
$347.01
24時間の取引高:
1.32M
Relative Volume:
0.61
時価総額：
$77.09B
収益：
$194.82B
当期純損益:
$5.53B
株価収益率:
14.00
EPS:
24.4514
ネットキャッシュフロー:
$3.77B
1週間 パフォーマンス:
-1.84%
1か月 パフォーマンス:
+4.89%
6か月 パフォーマンス:
-20.16%
1年 パフォーマンス:
-18.30%
1日の値動き範囲:
$340.04
$349.02
1週間の範囲:
$335.10
$355.79
52週間の値動き範囲:
$273.71
$458.73
Elevance Health Inc Stock (ELV) Company Profile
名前
Elevance Health Inc
セクター
電話
(800) 331-1476
住所
220 VIRGINIA AVENUE, INDIANAPOLIS
ELV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
342.35 | 76.96B | 194.82B | 5.53B | 3.77B | 24.45 |
|
UNH
Unitedhealth Group Inc
|
362.50 | 326.45B | 422.82B | 22.09B | 25.27B | 23.09 |
|
CVS
Cvs Health Corp
|
81.93 | 102.82B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
CI
Cigna Group
|
301.78 | 81.43B | 261.22B | 5.40B | 3.94B | 18.31 |
|
HUM
Humana Inc
|
290.65 | 35.04B | 123.11B | 1.58B | 2.44B | 13.03 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-14 | 開始されました | Goldman | Neutral |
| 2025-07-21 | ダウングレード | Argus | Buy → Hold |
| 2025-07-18 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | アップグレード | Argus | Hold → Buy |
| 2025-01-22 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | ダウングレード | Argus | Buy → Hold |
| 2024-07-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-06-24 | 開始されました | Morgan Stanley | Overweight |
| 2024-05-30 | 開始されました | Robert W. Baird | Outperform |
| 2024-03-06 | 開始されました | Barclays | Overweight |
| 2023-07-12 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-03-28 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-08-22 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
すべてを表示
Elevance Health Inc (ELV) 最新ニュース
How Elevance Health Inc. (A58) stock correlates with oil markets2025 Major Catalysts & Smart Money Movement Alerts - newser.com
How Elevance Health Inc. stock reacts to Fed rate cutsWeekly Gains Summary & Weekly Breakout Stock Alerts - newser.com
Advanced analytics toolkit walkthrough for Elevance Health Inc.Market Trend Summary & Community Verified Trade Signals - newser.com
Trend analysis for Elevance Health Inc. this weekJuly 2025 News Drivers & Safe Entry Trade Signal Reports - newser.com
Has Elevance Health Inc. formed a bullish divergenceWeekly Investment Report & Weekly Hot Stock Watchlists - newser.com
Elevance to penalize facilities for out-of-network providers - Modern Healthcare
Bernstein Adjusts Elevance Health Price Target to $412 From $420 - MarketScreener
Elevance Health Inc: A Key Exit in Eaton Vance Worldwide Health Sciences Fund's Q3 2025 Portfolio - Yahoo Finance
Is Elevance Health Inc. stock trading at a premium valuation2025 Market Trends & Expert Curated Trade Ideas - newser.com
Elevance Health: Q3 Figures Underscore Slow But Steady Recovery (NYSE:ELV) - Seeking Alpha
What momentum indicators show for Elevance Health Inc. stock - newser.com
Why Elevance Health Inc. (A58) stock attracts wealthy investorsGlobal Markets & High Accuracy Buy Signal Tips - newser.com
Will Elevance Health Inc. stock outperform global peersJuly 2025 Chart Watch & Free Weekly Chart Analysis and Trade Guides - newser.com
Elevance Health Stock To Rally 10%? Analyst Sees Upside After Q3 Print, Retail Bulls Feel It’s ‘Time To Buy’ - Stocktwits
Wells Fargo Reaffirms Their Buy Rating on Elevance Health (ELV) - The Globe and Mail
Centene And Oscar Health Stocks Sink After Molina Warning - Benzinga
TD Cowen Raises Price Target for Elevance Health (ELV) to $380 | - GuruFocus
TD Cowen Adjusts Price Target on Elevance Health to $380 From $330, Maintains Buy Rating - MarketScreener
Molina tumbles on profit forecast cut, drags broader health insurance stocks - Reuters
Elevance Health (ELV) Gets a Buy from Truist Financial - The Globe and Mail
Is Elevance Health Inc. stock supported by strong cash flowsJuly 2025 News Drivers & AI Powered Market Entry Ideas - newser.com
Elevance Health (ELV) Announces Fiscal Q3 2025 Results - Insider Monkey
HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members - Social News XYZ
Barclays Maintains Elevance Health (ELV) Overweight Recommendation - Nasdaq
Elevance Health Named Top Dividend Stock With Insider Buying and 1.96% Yield (ELV) - Nasdaq
Elevance CFO: 2026 Should Mark ‘The Trough’ For Medicaid Margins - HCI Innovation Group
Leerink Partners Adjusts Price Target on Elevance Health to $350 From $310, Maintains Market Perform Rating - MarketScreener
Goldman Sachs Adjusts Price Target on Elevance Health to $331 From $343, Maintains Neutral Rating - MarketScreener
Barclays Adjusts Price Target on Elevance Health to $385 From $395, Maintains Overweight Rating - MarketScreener
Barclays Lowers Price Target for Elevance Health (ELV) to $385 | ELV Stock News - GuruFocus
Elevance: Checking Out The Q3 Test Results (NYSE:ELV) - Seeking Alpha
Elevance Health (ELV) Margin Decline Challenges Bullish Earnings Growth Narratives - Yahoo Finance
Historical volatility pattern of Elevance Health Inc. visualized2025 Macro Impact & Low Risk Entry Point Tips - newser.com
Elevance Health Reports Strong Q3 2025 Revenue Growth - TipRanks
Elevance Health Inc (ELV): A Strategic SWOT Insight - GuruFocus
Elevance Health: Q3 Earnings Snapshot - Stamford Advocate
Visual trend scoring systems applied to Elevance Health Inc.July 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
Elevance Health Inc (ELV) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Medicaid ... By GuruFocus - Investing.com Canada
Elevance Health execs expect Medicaid costs to rise in 2026 - Fierce Healthcare
Elevance Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Elevance Health Inc (ELV) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Medicaid ... - Yahoo Finance
Why Is Elevance Health Stock Falling Tuesday?Elevance Health (NYSE:ELV) - Benzinga
Elevance health unfazed by 'elevated' commercial group medical costs - BenefitsPRO
Elevance Health Q3 Earnings Beat Estimates on Strong MA Membership - Zacks Investment Research
Elevance Health Inc (ELV) Q3 2025 Earnings Call Highlights: Stro - GuruFocus
Elevance Health, Inc. Declares Fourth Quarter Dividend, Payable on December 19, 2025 - MarketScreener
What’s next for Elevance Health Inc. stock priceMarket Growth Review & Safe Swing Trade Setups - newser.com
Elevance flags higher costs in Medicaid business in 2026, shares retreat - Reuters
Elevance Health Inc (ELV) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
1.06%
大文字化:
|
ボリューム (24 時間):